Evidence map›Paper›PMID 32060212›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Intraoperative

Christopher Darr, Nina N Harke, Jan Philipp Radtke, Leubet Yirga, Claudia Kesch, Maarten R Grootendorst, Wolfgang P Fendler, Pedro Fragoso Costa, Christoph Rischpler, Christine Praus and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Real-time diagnosis of sampled lesions in targeted biopsy of prostate Cancer using a novel tracer [European journal of nuclear medicine and molecular imaging · 2025
    Article
  9. Review
  10. Article
  11. Current clinical applications of Cerenkov luminescence for intraoperative molecular imaging.European journal of nuclear medicine and molecular imaging · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  16. Radiation Protection and Occupational Exposure onJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  17. Observational
  18. Cerenkov Luminescence Imaging in Prostate Cancer: Not the Only Light That Shines.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Christopher DarrDepartment of Urology, University Hospital Essen, Essen, Germany christopher.darr@uk-essen.de.
Nina N HarkeDepartment of Urology, University Hospital Essen, Essen, Germany.
Jan Philipp RadtkeDepartment of Urology, University Hospital Essen, Essen, Germany.
Leubet YirgaDepartment of Urology, University Hospital Essen, Essen, Germany.
Claudia KeschDepartment of Urology, University Hospital Essen, Essen, Germany.
Maarten R GrootendorstClinical Research, Lightpoint Medical Ltd., Chesham, United Kingdom.
Wolfgang P FendlerDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Pedro Fragoso CostaDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Christoph RischplerDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Christine PrausDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Johannes HauboldInstitute of Diagnostics and Radiology, University Hospital Essen, Essen, Germany.
Henning ReisInstitute of Pathology, University Duisburg-Essen, Essen, Germany; and.
Thomas HagerInstitute of Pathology, University Duisburg-Essen, Essen, Germany; and.
Ken HerrmannDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Ina BinseDepartment of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Boris HadaschikDepartment of Urology, University Hospital Essen, Essen, Germany.
Essen University Hospital · DEUniversity of Duisburg-Essen · DELightpoint Medical (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our objective was to assess the feasibility and accuracy of Cerenkov luminescence imaging (CLI) for assessment of surgical margins intraoperatively during radical prostatectomy.

Indexed as

OligopeptidesAgedAged, 80 and overEdetic AcidFeasibility StudiesGallium IsotopesGallium RadioisotopesHumansKallikreinsLuminescent MeasurementsMaleMargins of ExcisionMiddle AgedPositron Emission Tomography Computed TomographyProstatectomyProstate-Specific AntigenEdetic Acidgallium 68 PSMA-11Gallium IsotopesGallium RadioisotopesKallikreinsKLK3 protein, humanOligopeptidesProstate-Specific AntigenCerenkov luminescence imagingmargin assessmentprostate cancerradical prostatectomyradioguided surgery

Identifiers

PMID32060212
PMCPMC7539648
OpenAlexW3005583034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.